524 studies found for:    MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1
Show Display Options
Rank Status Study
21 Completed Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Laxymig ER (drug)
22 Completed Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Dronabinol MDI
23 Completed Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Maxalt 10mg MLT plus Caffeine 75mg;   Drug: Maxalt 10mg MLT plus Placebo;   Drug: Placebo + Placebo
24 Recruiting Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Other: Sham chiropractic manipulative therapy;   Other: Chiropractic spinal manipulative therapy
25 Completed Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Sumatriptan+Promethazine (SPr)
26 Completed Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
27 Completed Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Placebo;   Drug: Eletriptan HBr 40 mg;   Drug: Eletriptan HBr 80 mg
28 Completed Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
29 Unknown  Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura
Condition: Migraine With Aura
Interventions: Drug: NXN-188;   Drug: Placebo
30 Completed Impact of tDCS on Cerebral Autoregulation
Conditions: Cerebral Microangiopathy;   CADASIL;   Migraine With Aura;   ICA Stenosis
Interventions: Device: Anodal tDCS;   Device: Cathodal tDCS;   Device: sham tDCS
31 Recruiting Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia
Conditions: Headache;   Migraine;   Aura
Interventions: Other: Hypoxia;   Other: Placebo
32 Completed
Has Results
A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Migraine, Acute;   Migraine Headaches
Interventions: Drug: sumatriptan and naproxen sodium combination tablet;   Drug: sumatriptan tablet;   Drug: naproxen sodium tablet
33 Completed
Has Results
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Migraine
Interventions: Drug: Placebo;   Drug: Combination Product (sumatriptan succinate/naproxen sodium)
34 Completed An Open-labeled Trial of Ramipril in Patients With Migraine
Condition: Migraine With Hypertension
Intervention: Drug: Ramipril
35 Completed
Has Results
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Migraine, Acute
Interventions: Drug: Combination Product (sumatriptan succinate / naproxen sodium);   Drug: Placebo
36 Recruiting Migraine and Body Composition
Conditions: Migraine With and Without Aura;   Chronic Migraine;   Healthy Controls
Intervention:
37 Completed TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine
Conditions: Migraine With or Without Aura;   Migraine Disorders
Interventions: Drug: Combination Product (sumatriptan succinate / naproxen sodium);   Drug: RELPAX(eletriptan) 40mg Tablet
38 Completed An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Cluster Headache;   Migraine
Interventions: Drug: TREXIMA™;   Drug: IMITREX® (4mg);   Drug: IMITREX® (6mg);   Drug: IMITREX Tablet 100mg
39 Completed Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine
Condition: Migraine With or Without Aura
Interventions: Drug: Placebo;   Drug: Eletriptan 20 mg;   Drug: Eletriptan 40 mg;   Drug: Eletriptan 80 mg
40 Completed Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan
Condition: Migraine With or Without Aura
Interventions: Drug: Placebo;   Drug: Eletriptan 40 mg;   Drug: Eletriptan 80 mg

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years